Registration number:
Acculabs Diagnostics UK Limited
for the
Year Ended 31 December 2017
Acculabs Diagnostics UK Limited
Contents
Company Information |
|
Statement of Financial Position |
|
Notes to the Financial Statements |
Acculabs Diagnostics UK Limited
Company Information
Directors |
Mr C Gordon Mr R Singh |
Company secretary |
Mrs S Gordon |
Registered office |
|
Accountants |
|
1 |
Acculabs Diagnostics UK Limited
(Registration number: 07179157)
Statement of Financial Position as at 31 December 2017
Note |
2017 |
2016 |
|
Fixed assets |
|||
Intangible assets |
|
|
|
Tangible assets |
|
|
|
|
|
||
Current assets |
|||
Stocks |
|
|
|
Debtors |
|
|
|
Cash at bank and in hand |
|
|
|
|
|
||
Creditors: Amounts falling due within one year |
( |
( |
|
Net current liabilities |
( |
( |
|
Total assets less current liabilities |
|
|
|
Creditors: Amounts falling due after more than one year |
( |
( |
|
Provisions for liabilities |
( |
( |
|
Net assets/(liabilities) |
|
( |
|
Capital and reserves |
|||
Called up share capital |
|
|
|
Profit and loss account |
|
( |
|
Total equity |
|
( |
For the financial year ending 31 December 2017 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors' responsibilities:
• |
|
• |
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements. |
These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies' regime within Part 15 of the Companies Act 2006.
2 |
Acculabs Diagnostics UK Limited
(Registration number: 07179157)
Statement of Financial Position as at 31 December 2017 (continued)
These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies' regime and the option not to file the Income Statement has been taken.
Approved and authorised by the
......................................... |
3 |
Acculabs Diagnostics UK Limited
Notes to the Financial Statements for the Year Ended 31 December 2017
General information |
The company is a private company limited by share capital, incorporated in England and Wales.
The address of its registered office is
Accounting policies |
Summary of significant accounting policies and key accounting estimates
The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.
Statement of compliance
These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A - 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' and the Companies Act 2006.
Basis of preparation
These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.
These financial statements are prepared in sterling which is the functional currency of the entity.
4 |
Acculabs Diagnostics UK Limited
Notes to the Financial Statements for the Year Ended 31 December 2017 (continued)
2 |
Accounting policies (continued) |
Judgements
The judgements (apart from those involving estimations) that management has made in the process of applying the entity's accounting policies and that have the most significant effect on the amounts recognised in the financial statements are as follows: |
Assessing indicators of impairment - In assessing whether there have been indicators of impairment of assets, the directors have considered both external and internal sources of information such as market conditions, counterparty credit ratings and experience of recoverability. |
Assessing nature of lease - The Company has entered into commercial leases and as a lessee it obtains use of property, plant and equipment. The classification as operating or finance lease requires the Company to determine, based on an evaluation of the terms and conditions of the arrangements, whether it acquires the significant risks and rewards of ownership of these assets and accordingly whether the lease requires an asset and liability to be recognised in the balance sheet. |
Revenue recognition
Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.
The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.
5 |
Acculabs Diagnostics UK Limited
Notes to the Financial Statements for the Year Ended 31 December 2017 (continued)
2 |
Accounting policies (continued) |
Government grants
Government grants are recognised at the fair value of the asset received or receivable. Grants are not recognised until there is reasonable assurance that the company will comply with the conditions attaching to them and the grants will be received.
Government grants are recognised using the accrual model and the performance model.
Under the accrual model, government grants relating to revenue are recognised on a systematic basis over the periods in which the company recognises the related costs for which the grant is intended to compensate. Grants that are receivable as compensation for expenses or losses already incurred or for the purpose of giving immediate financial support to the entity with no future related costs are recognised in income in the period in which it becomes receivable.
Grants relating to assets are recognised in income on a systematic basis over the expected useful life of the asset. Where part of a grant relating to an asset is deferred, it is recognised as deferred income and not deducted from the carrying amount of the asset.
Under the performance model, where the grant does not impose specified future performance-related conditions on the recipient, it is recognised in income when the grant proceeds are received or receivable. Where the grant does impose specified future performance-related conditions on the recipient, it is recognised in income only when the performance-related conditions have been met. Where grants received are prior to satisfying the revenue recognition criteria, they are recognised as a liability.
Tax
The tax expense for the period comprises deferred tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.
Deferred tax is recognised in respect of all timing differences between taxable profits and profits reported in the financial statements.
Unrelieved tax losses and other deferred tax assets are recognised when it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.
Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference.
Tangible assets
Tangible assets are stated in the statement of financial position at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.
The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.
6 |
Acculabs Diagnostics UK Limited
Notes to the Financial Statements for the Year Ended 31 December 2017 (continued)
2 |
Accounting policies (continued) |
Depreciation
Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:
Asset class |
Depreciation method and rate |
Leasehold property |
20% straight line |
Laboratory equipment, fixtures and fittings and office equipment |
20% straight line |
Intangible assets
Tangible assets are initially recorded at cost, and subsequently stated at cost less any accumulated depreciation and impairment losses. Any tangible assets carried at revalued amounts are recorded at the fair value at the date of revaluation less any subsequent accumulated depreciation and subsequent accumulated impairment losses.
Amortisation
Amortisation is provided on intangible assets so as to write off the cost, less any estimated residual value, over their useful life as follows:
Asset class |
Amortisation method and rate |
Development costs |
20%-33% straight line |
Cash and cash equivalents
Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.
Trade debtors
Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.
Trade debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.
Stocks
Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost is determined using the first-in, first-out (FIFO) method.
The cost of finished goods and work in progress comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the inventories to their present location and condition. At each reporting date, stocks are assessed for impairment. If stocks are impaired, the carrying amount is reduced to its selling price less costs to complete and sell; the impairment loss is recognised immediately in profit or loss.
7 |
Acculabs Diagnostics UK Limited
Notes to the Financial Statements for the Year Ended 31 December 2017 (continued)
2 |
Accounting policies (continued) |
Trade creditors
Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.
Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.
Leases
Leases in which substantially all the risks and rewards of ownership are retained by the lessor are classified as operating leases. Payments made under operating leases are charged to profit or loss on a straight-line basis over the period of the lease.
Share capital
Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.
Defined contribution pension obligation
A defined contribution plan is a pension plan under which fixed contributions are paid into a pension fund and the company has no legal or constructive obligation to pay further contributions even if the fund does not hold sufficient assets to pay all employees the benefits relating to employee service in the current and prior periods.
Contributions to defined contribution plans are recognised as employee benefit expense when they are due. If contribution payments exceed the contribution due for service, the excess is recognised as a prepayment.
Research and development
Research and development expenditure is recognised as an expense in the period in which it is incurred.
8 |
Acculabs Diagnostics UK Limited
Notes to the Financial Statements for the Year Ended 31 December 2017 (continued)
Staff numbers |
The average number of persons employed by the company (including directors) during the year, was
Intangible assets |
Development costs |
Total |
|
Cost or valuation |
||
At 1 January 2017 |
|
|
Additions acquired separately |
|
|
At 31 December 2017 |
|
|
Amortisation |
||
At 1 January 2017 |
|
|
Amortisation charge |
|
|
At 31 December 2017 |
|
|
Carrying amount |
||
At 31 December 2017 |
|
|
At 31 December 2016 |
|
|
The aggregate amount of research and development expenditure recognised as an expense during the period is £
9 |
Acculabs Diagnostics UK Limited
Notes to the Financial Statements for the Year Ended 31 December 2017 (continued)
Tangible assets |
Land and buildings |
Other plant and machinery |
Total |
|
Cost or valuation |
|||
At 1 January 2017 |
|
|
|
Additions |
- |
|
|
At 31 December 2017 |
|
|
|
Depreciation |
|||
At 1 January 2017 |
|
|
|
Charge for the year |
- |
|
|
At 31 December 2017 |
|
|
|
Carrying amount |
|||
At 31 December 2017 |
- |
|
|
At 31 December 2016 |
- |
|
|
Stocks |
2017 |
2016 |
|
Other inventories |
|
|
Debtors |
2017 |
2016 |
|
Trade debtors |
|
|
Directors loan accounts |
57,226 |
10,920 |
Other debtors |
|
|
|
|
10 |
Acculabs Diagnostics UK Limited
Notes to the Financial Statements for the Year Ended 31 December 2017 (continued)
Creditors |
Creditors: amounts falling due within one year
2017 |
2016 |
|
Due within one year |
||
Trade creditors |
|
|
Taxation and social security |
|
|
Deferred income |
|
|
Other creditors |
|
|
|
|
Creditors includes debt secured against assets of the company of £188,240 (2016 - £229,967).
Creditors: amounts falling due after more than one year
2017 |
2016 |
|
Due after one year |
||
Other non-current financial liabilities |
|
|
Creditors include debt secured against assets of the company of £13,838 (2016 - £41,461).
Financial commitments, guarantees and contingencies |
Amounts not provided for in the balance sheet
The total amount of financial commitments not included in the balance sheet is £
11 |
Acculabs Diagnostics UK Limited
Notes to the Financial Statements for the Year Ended 31 December 2017 (continued)
9 |
Financial commitments, guarantees and contingencies (continued) |
Amounts disclosed in the balance sheet
Included in the balance sheet are pensions of £780 (2016 - £Nil).
Related party transactions |
Transactions with directors |
2017 |
At 1 January 2017 |
Advances to directors |
Repayments by director |
At 31 December 2017 |
Mr C Gordon |
||||
|
10,920 |
|
( |
|
2016 |
Advances to directors |
Repayments by director |
At 31 December 2016 |
Mr C Gordon |
|||
|
|
( |
|
Summary of transactions with other related parties
12 |